Download [ Insert Title Here ]

Survey
yes no Was this document useful for you?
   Thank you for your participation!

* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project

Document related concepts

Race and health wikipedia , lookup

Infection control wikipedia , lookup

Patient safety wikipedia , lookup

Epidemiology of metabolic syndrome wikipedia , lookup

Adherence (medicine) wikipedia , lookup

List of medical mnemonics wikipedia , lookup

Multiple sclerosis research wikipedia , lookup

Transcript
10 Points to Remember on An Effective
Approach to High Blood Pressure Control
Summary Prepared by Debabrata Mukherjee, MD
Point 1
Hypertension currently affects nearly 78 million
adults in the United States and is also a major
modifiable risk factor for other cardiovascular
diseases and stroke.
Point 2
High-quality blood pressure management is
multifactorial and requires engagement of patients,
families, providers, and health care delivery systems
and communities. This includes expanding patient
and health care provider awareness, appropriate
lifestyle modifications, access to care, evidencebased treatment, a high level of medication
adherence, and adequate follow-up.
Point 3
The identification of best practice, evidence-based
management algorithms leading to standardization of
treatment, is a critical element in helping to achieve
national blood pressure control goals at a population
level.
Point 4
Developing, disseminating, and implementing an
effective hypertension treatment algorithm is a
critical part of a multipronged systematic approach to
controlling hypertension, as it facilitates clinical
decision making, provides a default approach with
proven benefits, and engages multiple providers in a
coordinated manner.
Point 5
The blood pressure goal for an individual is set
by utilizing a combination of factors including
scientific evidence, clinical judgment, and
patient tolerance. For most people, the goal is
<140 and <90; however, lower targets may be
appropriate for some populations such as
African-Americans, the elderly, or patients with
left ventricular hypertrophy, systolic or diastolic
left ventricular dysfunction, diabetes mellitus,
or chronic kidney disease.
Point 6
Lifestyle modifications should be initiated in all
patients with hypertension, and they should be
assessed for target organ damage and existing
cardiovascular disease.
Point 7
Self-monitoring is encouraged for most
patients throughout their care, and requesting
and reviewing readings from home and
community settings can help the provider
assist the patient in achieving and maintaining
good control.
Point 8
Treatment guidelines serve to facilitate a
systematic approach to the management of
hypertension, but provide appropriate
modifications based on specific patient
characteristics, preferences, and other
pragmatic factors (e.g., cost, pill burden, risks
of certain side effects) to optimize a
personalized approach to the care of individual
patients. Consider thiazides as first-line
therapy in most patients.
Point 9
For patients with hypertension in combination with certain clinical
conditions, specific medications should be considered first-line treatments.
These include for:
– Coronary artery disease/post-myocardial infarction: beta-blocker
(BB), angiotensin-converting enzyme inhibitor (ACEI);
– Systolic heart failure: ACEI or angiotensin-receptor blocker (ARB),
BB, aldosterone antagonist, thiazide;
– Diastolic heart failure: ACEI or ARB, BB, thiazide;
– Diabetes: ACEI or ARB, thiazide, BB, calcium channel blocker;
– Kidney disease: ACEI or ARB; and
– Stroke or transient ischemic attack (TIA): thiazide, ACEI.
Point 10
The prevention of heart disease and stroke
mandates a greater emphasis on the
population-wide improvement of blood
pressure awareness, treatment, and control,
together with other cardiovascular health
factors.